New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1709-0.0091 (-5.06%)
At close: 04:00PM EDT
0.1788 +0.01 (+4.62%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.41M
Enterprise value -26.16M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)219.95
Price/book (mrq)0.43
Enterprise value/revenue -268.77
Enterprise value/EBITDA 0.68

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-84.17%
S&P500 52-week change 3-16.88%
52-week high 31.1100
52-week low 30.1700
50-day moving average 30.2330
200-day moving average 30.3661

Share statistics

Avg vol (3-month) 3852.85k
Avg vol (10-day) 3631.63k
Shares outstanding 5125.27M
Implied shares outstanding 6N/A
Float 8124.67M
% held by insiders 10.48%
% held by institutions 125.07%
Shares short (30 Aug 2022) 43.8M
Short ratio (30 Aug 2022) 42.81
Short % of float (30 Aug 2022) 43.04%
Short % of shares outstanding (30 Aug 2022) 43.03%
Shares short (prior month 28 Jul 2022) 43.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 0.00%
Operating margin (ttm)-40,823.79%

Management effectiveness

Return on assets (ttm)-24.50%
Return on equity (ttm)-55.56%

Income statement

Revenue (ttm)97.32k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-35.56M
EBITDA -38.88M
Net income avi to common (ttm)-35.12M
Diluted EPS (ttm)-0.3120
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)73.3M
Total cash per share (mrq)0.58
Total debt (mrq)25.74M
Total debt/equity (mrq)52.03
Current ratio (mrq)4.81
Book value per share (mrq)0.40

Cash flow statement

Operating cash flow (ttm)-31.69M
Levered free cash flow (ttm)-24.32M